CMI/Compas Programmatic Buying Platform AdMission Honored as Top Innovation by PharmaVOICE

King of Prussia, PA (PRWEB) April 06, 2015

AdMission is honored as a top innovation in pharmaceutical marketing by PharmaVOICE in the April Innovation Issue. As published in PharmaVOICE: CMI/Compas AdMission can deliver ads to target physicians when and where they are online. It is a programmatic buying active platform to consistently reach and deliver messages to target healthcare providers in their daily digital environment maximizing the effectiveness of a pharmaceutical brands advertising or promotional campaign. AdMission, launched in 2014, is the absolute latest in buying technology, delivering unparalleled engagement.

By combining the industrys only HCP-level multi-channel promotional access and affinity database covering over 1.3 million MDs, DOs, NPs, PAs, RNs, Pharmacists, and medical students, with the industrys first programmatic buying platform targeting physicians, CMI/Compas offers a level of accountability and addressability with digital display advertising that previously did not exist. ByDoctor

Leave a Reply